Navigation Links
French Lifestyle Secret Finally Revealed: Lycotec Publishes Unexpected Findings on Roquefort Cheese
Date:12/11/2012

CAMBRIDGE, England, Dec. 11, 2012 /PRNewswire/ -- The Lycotec team has recently started to publish its findings on the French cheese, Roquefort, in "Could cheese be the missing piece in the French paradox puzzle?" Unexpected anti-inflammatory factors discovered in this blue-vein cheese could lead to the development of a new generation of pharmaceuticals and future cosmetic products.

In this first publication, the authors Dr. Ivan Petyaev and Dr. Yuriy Bashmakov suggest that regular consumption of Roquefort, Camembert and other moulded fermented cheeses could be the answer to some of today's key health problems. Despite a diet high in saturated fats, France has been known to have the lowest rate of cardiovascular mortality. Today, the real secret to this lifestyle has been revealed. Eat more mouldy cheese!

Extensive laboratory and clinical validation by the Lycotec doctors and scientists have demonstrated that these anti-inflammatory factors, which occur during the ripening of the cheese, have unique properties which work best in acidic environments. The most notable two environments affected by these smelly cheeses include the stomach lining and skin surface.

In fact, the anti-inflammatory factors found in these cheeses could be extracted and used independently or as a part of today's pharmaceutical or beauty products. Moreover, there is a growing consensus that sub-clinical inflammation is behind many aging processes, from the loss of skeletal muscles and cellulite to metabolic, cardiovascular and cerebrovascular diseases.

The Lycotec Team urges pharmaceutical and beauty product companies to take a look at this new publication for future product ideas and partnerships, without the mouldy smell.

About the Lycotec Team:

Based in Cambridge, Lycotec focuses on the development and commercialisation of its proprietary bio-medical technologies for pharmaceutical, nutraceutical and functional food industries.

For more information please contact info(at)lycotec(dot)com

Media Contact:
Ivan Petyaev
petyaev(at)lycotec(dot)com
07921363740
Lycotec
http://www.lycotec.com  

 


'/>"/>
SOURCE Lycotec
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
2. Pycnogenol® (French Maritime Pine Bark Extract) Shown To Improve Endothelial Function And Reduce Oxidative Stress In New Clinical Trial
3. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
4. Cardinal Health Honored With Best Employers for Healthy Lifestyles Award by National Business Group on Health
5. Data Underscore Promise of Satori Pharmaceuticals Gamma-Secretase Modulator Program in Treatment of Alzheimers Disease
6. Satori Pharmaceuticals to Present Data Highlighting Promise of Gamma-Secretase Modulators in Treatment of Alzheimers Disease
7. Total Therapeutic Management, Inc. invites directors of quality improvement to learn secrets of provider engagement strategies
8. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
9. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
10. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
11. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 2017 Ascendis Pharma A/S (Nasdaq: ASND), a ... address significant unmet medical needs in rare diseases, today ... and webcast on Monday, April 3 during ENDO 2017, ... Orlando, Florida , to discuss new data ... Hormone, TransCon PTH and TransCon CNP). Ascendis ...
(Date:3/23/2017)... - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") ... that AB Laboratories Inc. ("AB Labs") has successfully completed ... the Access to Cannabis for Medical Purposes Regulations ("ACMPR") ... The facility, which was licensed for Cultivation ... at half capacity, with full production capacity scheduled by ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, a privately ... completion of the strategic executive team expansion needed to further optimize growth and ... executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, ... build on a solid foundation. As experts in dangerous situations the Inflow IQ ... coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Force Dagger Foundation the US Special Operations Command’s Patriot Award. The award was ... Thomas thanked Task Force Dagger Foundation for its significant and enduring support to ...
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “The Trainer”: an ... published author, Scotty, a fiction writer with an active imagination and an enthusiasm for ... book follows the tale of Wild Bill Hart, who sat looking at the thirty-three ...
Breaking Medicine News(10 mins):